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s  u  m  m  a  r  y
We  report  the  case  of a 74-year-old  woman  who  presented  with  recurrent  episodes  of  polymorphic
ventricular  tachycardia  (PVT)  with  a normal  QT  interval  due  to digitalis  intoxication  (serum  digoxin
concentration,  5.0  ng/mL)  and  severe  hyperkalemia  (serum  potassium  level,  8.3  mEq/L).  In  addition,  lab-
oratory data  showed  elevated  levels  of  blood  urea  nitrogen  (54  mg/dL)  and  serum  creatinine  (1.57  mg/dL),
suggesting  dehydration.  She  had  been  treated  with  a combination  of digoxin  and  eplerenone  for  atrial
ﬁbrillation  and  heart  failure.  The  PVT  resolved  after  treatment  for  hyperkalemia.  Cardiac  magnetic  res-
onance  imaging  and  left  ventriculography  showed  left ventricular  hypertrophy  predominantly  in  the
apex,  suggesting  apical  hypertrophic  cardiomyopathy  (HCM).  We  presume  that  the  presence  of  HCMyperkalemia
plerenone
was related  to the  occurrence  of  PVT  in  this patient  with  digitalis  intoxication  and  hyperkalemia.
<Learning  objective:  PVT  with  a normal  QT  interval  caused  by  digitalis  intoxication  with  hyperkalemia
was  observed  in  a patient  with  HCM  treated  with  digoxin  and  eplerenone  for atrial  ﬁbrillation  and  heart
failure.  The  presence  of  HCM  may  be related  to the  occurrence  of PVT.  Combination  therapy  with  digoxin
and aldosterone  receptor  antagonist  may  predispose  severe  hyperkalemia,  and  monitoring  of  serum
digitalis  concentration  and  potassium  level should  be  done  strictly.>
©  2012  Japanese  College  of Cardiology.  Published  by  Elsevier  Ltd.  All rights  reserved.ntroduction
Polymorphic ventricular tachycardia (PVT) is a life-threatening
orm of arrhythmia that may  be associated with prolonged or nor-
al  QT intervals. PVT with a normal QT interval is most frequently
bserved in acute myocardial ischemia or infarction but may  also
e seen in other structural heart diseases such as cardiomyopa-
hy [1,2] or in the absence of organic heart disease (e.g. Brugada
yndrome [3],  catecholaminergic PVT [4],  or the short-coupled vari-
nt of torsade de pointes [5]). Severe digitalis intoxication causes
yperkalemia and malignant ventricular arrhythmia, necessitat-
ng prompt diagnosis and treatment [6–9]. Selective aldosterone
ntagonism with eplerenone in patients with heart failure is clearly
eneﬁcial but is associated with an increased risk of hyperkalemia
10]. Here, we present a case of PVT with a normal QT interval
n the setting of digitalis intoxication and hyperkalemia during
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ttp://dx.doi.org/10.1016/j.jccase.2012.06.012combination therapy with digoxin and eplerenone in a patient with
hypertrophic cardiomyopathy (HCM).
Case report
A 74-year-old woman with a history of type 2 diabetes mellitus
treated with insulin presented to our hospital with complaints of
fainting and vomiting after a 2-day history of nausea and anorexia.
She had been treated for permanent atrial ﬁbrillation and heart
failure with digoxin (0.25 mg/day) and furosemide (40 mg/day)
for12 years. Because her heart failure had not been well con-
trolled and she had frequently needed hospitalization due to the
exacerbation of symptoms, eplerenone (25 mg/day) was added to
the treatment regimen 16 months before admission. Four months
before admission, her serum creatinine level was within nor-
mal  limits (0.76 mg/dL), and her estimated glomerular ﬁltration
rate (eGFR) was mildly decreased (56.1 mL  min−1 × 1.73 m−2). Her
serum potassium level was normal (4.8 mEq/L) at that time. The
patient had no family history of heart disease or sudden cardiac
death.
vier Ltd. All rights reserved.






ligure 1. Electrocardiographic monitoring showing recurrent episodes of polymor-
hic ventricular tachycardia. Periods of accelerated idioventricular rhythm are also
bserved.
igure 2. (a) Electrocardiographic monitoring (ECG) showing accelerated idioventricular
rolonged QRS complexes and normal QT intervals. (c) ECG performed on the ﬁfth day a
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On admission, the patient’s height was  142 cm and her
body weight was  50 kg. Her pulse was  weak and irregular,
and her blood pressure could not be measured. Electrocardio-
graphic (ECG) monitoring showed recurrent episodes of PVT;
periods of accelerated idioventricular rhythm (AIVR) were also
observed (Figs. 1 and 2a). Twelve-lead ECG performed between
episodes of tachycardia showed that the QRS complex was
widened, but the QT interval was  not prolonged (Fig. 2b).
Laboratory assessment showed marked hyperkalemia (serum
potassium level, 8.3 mEq/L) and elevated levels of blood urea
nitrogen (54 mg/dL) and serum creatinine (1.57 mg/dL). The calcu-
lated transtubular potassium gradient was low (3.5; normal range,
8–9), suggesting hypoaldosteronism. The patient was diagnosed
with PVT complicated with digitalis intoxication and hyperkalemia
induced by dehydration; high serum digoxin concentration was
conﬁrmed later (5.0 ng/mL; therapeutic range, 0.8–2.0). Digoxin
and eplerenone were discontinued, and intravenous administra-
tion of lidocaine was  initially used because myocardial ischemia
 rhythm. (b) ECG performed between episodes of ventricular tachycardia showing
fter admission showing atrial ﬁbrillation and negative T waves in I, aVL, and V4-6
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oigure 3. Cardiac magnetic resonance imaging at end-diastole (a, c) and end-systo
eft  ventriculography at end-diastole (e) and end-systole (f) showing left ventricular
AO,  right anterior oblique.
as not completely denied as the cause of PVT, but it was  discon-
inued soon after because it was not effective for the suppression
f PVT. We  treated hyperkalemia with glucose-insulin solution (14
nits of regular insulin in 500 mL  of 10% glucose), intravenous
odium bicarbonate (24 mEq), and K+-exchange resin (calcium
olystyrene sulfonate) administered orally (3 g) and rectally (30 g).
our hours later, the patient’s serum potassium level decreased
o 6.3 mEq/L, and her PVT resolved. On the next day, her serum
otassium and digoxin levels decreased to 5.3 mEq/L and 2.3 ng/mL,
espectively, and PVT did not recur.
ECG performed on the ﬁfth day after admission showed atrial
brillation and negative T waves in I, aVL, and V4-6 leads (Fig. 2c).
chocardiography showed asymmetric septal hypertrophy with no
vidence of left ventricular outﬂow tract obstruction; however,
pical hypertrophy could not be conﬁrmed. Cardiac magnetic reso-
ance imaging showed left ventricular hypertrophy predominantly
n the apex (Fig. 3a–d). Coronary angiography did not show organic
tenosis, and left ventriculography showed a spade-like conﬁgura-
ion, suggesting apical HCM (Fig. 3e and f).
iscussion
We report a case of PVT with a normal QT interval caused
y digitalis intoxication with severe hyperkalemia in a patient
ith HCM. Digitalis intoxication causes hyperkalemia by inhibi-
ing Na+/K+-ATPase, thereby shifting potassium to the extracellular
ompartment [8,9]. Potassium replacement is effective for the
reatment of digitalis intoxication with hypokalemia. In con-
rast, digitalis intoxication with hyperkalemia or life-threatening
rrhythmia can be treated with digoxin-speciﬁc Fab antibody frag-
ents [11]. Because digoxin-speciﬁc Fab antibody fragments are
ot available in Japan, we treated our patient with lidocaine and
y lowering serum potassium levels. Recent guidelines indicate
hat lidocaine has a class IIb recommendation for the treatment
f PVT associated with acute myocardial ischemia or infarction andd) showing left ventricular hypertrophy predominantly in the apical myocardium.
rtrophy at the apex, producing a spade-like appearance of the left ventricular cavity.
a  class III recommendation for digitalis toxicity [1].  Because acute
myocardial ischemia could not be excluded in this patient, we used
lidocaine, which was not effective for the suppression of PVT. Dyck-
ner et al. reported a necropsy case of fatal digitalis intoxication in
which an intracellular potassium deﬁcit in the cardiac muscle was
conﬁrmed [12]. Therefore, we speculated that shifting potassium to
the intracellular compartment with glucose-insulin therapy would
potentially be effective for the suppression of PVT in this patient.
Digitalis intoxication causes various ventricular arrhythmias
such as ventricular premature complexes, ventricular tachycar-
dia, and ventricular ﬁbrillation; moreover, bidirectional ventricular
tachycardia is particularly characteristic of digitalis intoxication
[6,7]. To the best of our knowledge, this is the ﬁrst report of PVT
complicated with digitalis intoxication in a patient with HCM.
Although digitalis intoxication causes various arrhythmias, ventri-
cular tachyarrhythmias are uncommon in patients with a healthy
heart and are usually observed in older patients with underlying
heart disease [6,7]. This observation may  be due to the exacerbation
of enhanced Purkinje ﬁber automaticity by ischemia, ﬁber stretch,
or other injuries [6].  Watson et al. speculated that inducible PVT
in patients with HCM might be related to the underlying myocar-
dial architecture, characterized by myocardial cellular disarray and
ﬁbrosis [13]. Therefore, we suppose that the occurrence of PVT in
this patient was  due to the underlying HCM. In addition to PVT,
AIVR was observed in this patient. When AIVR is associated with
digitalis intoxication, the main mechanism involved is triggered
activity [14]. Although ventricular arrhythmias of digitalis intox-
ication are primarily due to enhanced automaticity and triggered
activity [6],  digitalis can also predispose reentry by shortening the
effective refractory period of the ventricular muscle [15]. We specu-
late that reentry with an arrhythmogenic substrate in HCM was the
mechanism of PVT in this patient; however, enhanced automaticity
and triggered activity are other possible mechanisms.
Although spironolactone can decrease digoxin clearance and



























Steiness E. Spironolactone-induced changes in digoxin kinetics. Clin Pharmacol
Ther 1978;24:162–7.K. Mori et al. / Journal of Car
eported to have no signiﬁcant pharmacokinetic interaction with
igoxin [16,17]. However, combination therapy with digoxin and
n aldosterone receptor antagonist may  predispose the patient to
ife-threatening hyperkalemia. Although our patient’s serum cre-
tinine and potassium levels were within normal limits 4 months
efore admission, digitalis intoxication with life-threatening
yperkalemia developed during combination therapy with digoxin
nd eplerenone. We  speculate that the maintenance dose of digoxin
0.25 mg/day) may  have been too high for this patient because of
er mild renal dysfunction and advanced age.
onclusion
We  have reported a case of PVT complicated with digitalis intox-
cation and severe hyperkalemia during combination therapy with
igoxin and eplerenone in a patient with HCM. This patient was
uccessfully treated by lowering serum potassium levels. Careful
onitoring of serum potassium levels is highly recommended in
lderly patients treated with digoxin and eplerenone, especially in
atients with an underlying myocardial disease such as HCM.
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